Last reviewed · How we verify
Placebo trazodone and placebo Sentra PM — Competitive Intelligence Brief
phase 3
Psychiatry/Sleep Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo trazodone and placebo Sentra PM (Placebo trazodone and placebo Sentra PM) — Targeted Medical Pharma. This is a placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo trazodone and placebo Sentra PM TARGET | Placebo trazodone and placebo Sentra PM | Targeted Medical Pharma | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo trazodone and placebo Sentra PM CI watch — RSS
- Placebo trazodone and placebo Sentra PM CI watch — Atom
- Placebo trazodone and placebo Sentra PM CI watch — JSON
- Placebo trazodone and placebo Sentra PM alone — RSS
Cite this brief
Drug Landscape (2026). Placebo trazodone and placebo Sentra PM — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-trazodone-and-placebo-sentra-pm. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab